Aino Health Q3 operating loss widens 53% year over year to SEK 1.57 million; Q3 net sales rise 6% to SEK 6.16 million

• Aino Health’s Q3 2026 pretax loss widened 53% year-over-year to SEK 1.98 million.
• Quarterly net sales rose 6% year-over-year to SEK 6.16 million.
• Cash totaled SEK 898,000 at September-end, while equity stood at negative SEK 13.45 million.
• A rights issue announced November 10 targets approximately SEK 13.6 million before costs, primarily for international SaaS expansion and product development.
• The November 5 HUS contract has an estimated value of EUR 520,000 excluding VAT over its initial 24-month term.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aino Health AB published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein.